Viral vectors for vaccine applications.
- Author:
Youngjoo CHOI
1
;
Jun CHANG
Author Information
- Publication Type:Review
- Keywords: Vaccines; Genetic vector; Adenoviridae; Poxviridae; Alphavirus
- MeSH: Adenoviridae; Alphavirus; Communicable Diseases; Disease Outbreaks; Genetic Vectors; Humans; Immunization; Molecular Biology; Poxviridae; Vaccines
- From:Clinical and Experimental Vaccine Research 2013;2(2):97-105
- CountryRepublic of Korea
- Language:English
- Abstract: Traditional approach of inactivated or live-attenuated vaccine immunization has resulted in impressive success in the reduction and control of infectious disease outbreaks. However, many pathogens remain less amenable to deal with the traditional vaccine strategies, and more appropriate vaccine strategy is in need. Recent discoveries that led to increased understanding of viral molecular biology and genetics has rendered the used of viruses as vaccine platforms and as potential anti-cancer agents. Due to their ability to effectively induce both humoral and cell-mediated immune responses, viral vectors are deemed as an attractive alternative to the traditional platforms to deliver vaccine antigens as well as to specifically target and kill tumor cells. With potential targets ranging from cancers to a vast number of infectious diseases, the benefits resulting from successful application of viral vectors to prevent and treat human diseases can be immense.
